InflaRx (IFRX) Interest & Investment Income (2017 - 2026)

InflaRx's (IFRX) quarterly Interest & Investment Income came in at $391928.2 in Q1 2026, down 24.54% year-on-year from $519382.7 in Q1 2025, and down 100.0% quarter-over-quarter from $2148.2 billion in Q4 2025.

InflaRx (IFRX) Interest & Investment Income (2017 - 2026) Analysis & Trends

InflaRx has disclosed Interest & Investment Income across 10 years of filings, most recently posting $391928.2 for Q1 2026.

  • Interest & Investment Income for Q1 2026 came in at $391928.2, down 24.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $391928.2 (down 24.54% YoY), and the FY2025 annual result was $2.1 million, down 37.12% from the prior year.
  • Interest & Investment Income came in at $391928.2 for Q1 2026 at InflaRx, down from $2148.2 billion in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $2148.2 billion in Q4 2025 to a low of $31382.8 in Q1 2022.
  • The 5-year median for Interest & Investment Income is $1.7 million (2025), against an average of $202.8 billion.
  • Across the five-year window, Interest & Investment Income surged 1559715401.69% in 2023 and sank 100.0% in 2024, its largest moves.
  • InflaRx's Interest & Investment Income stood at $201.4 billion in 2022, then slumped by 100.0% to $3.0 million in 2023, then decreased by 6.88% to $2.8 million in 2024, then jumped by 77544274.8% to $2148.2 billion in 2025, then sank by 100.0% to $391928.2 in 2026.
  • The last three Interest & Investment Income figures came in at $391928.2 (Q1 2026), $2148.2 billion (Q4 2025), and $1.7 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 597,319.59
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 40.10 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - 305,000.00
7 Psyence Biomedical 241.78 Bn 241.78 Bn - 103,341.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 114.80 Mn
9 Abivax 94.26 Bn 94.26 Bn - -14.79 Mn
10 InflaRx 764.68 Mn 764.68 Mn 10,877.40 391,928.18

Historic Data

Download Data
DateValue
Mar 31, 2026 391,928.18
Dec 31, 2025 2,148.16 Bn
Sep 30, 2025 1.70 Mn
Jun 30, 2025 1.15 Mn
Mar 31, 2025 519,382.67
Sep 30, 2024 2.77 Mn
Jun 30, 2024 1.89 Mn
Mar 31, 2024 986,879.27
Sep 30, 2023 2.97 Mn
Jun 30, 2023 1.68 Mn
Mar 31, 2023 489.48 Bn
Sep 30, 2022 201.41 Bn
Jun 30, 2022 117,762.51
Mar 31, 2022 31,382.81
Dec 31, 2021 125.14 Bn
Sep 30, 2021 101,376.26
Jun 30, 2021 70,551.04
Mar 31, 2021 27,697.59
Dec 31, 2020 1,058.40 Bn
Sep 30, 2020 986,840.71